Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron

Moderna MRNA, a formidable name among the vaccine developers, has been impressing investors with the stupendous rally since Nov 26. The stock gained about 20% on Nov 26, followed by an 11.8% rise on Nov 29. It is not a mystery that the ace COVID-19 vaccine developer has been witnessing its stock rallying on the fears surrounding the new coronavirus variant, omicron. The new variant is feared to be carrying the combined features of previous variants and can have high transmissibility and lower vaccine potency.

>, Click to get this free report, Zacks Investment Research” title=”Get it free >>, Click to get this free report, Zacks Investment Research”>

– Zacks

The new omicron strain of coronavirus was first detected in South Africa with numerous mutations (more than 30) to the spike protein (as stated in a CNBC article). The omicron variant has now been reported in the U.K., Israel, Belgium, the Netherlands, Germany, Italy, Australia and Hong Kong. Going on, the World Health Organization (WHO) has labeled the variant as a “variant of concern.”

Investors willing to ride Moderna’s gains amid concerns surrounding the omicron variant can consider ETFs like ETFMG Treatments Testing and Advancements ETF GERM, VanEck Biotech ETF BBH, iShares Biotechnology ETF IBB and iShares Genomics Immunology and Healthcare ETF IDNA.

Moderna’s Chief Medical Officer Paul Burton recently commented that “We should know about the ability of the current vaccine to provide protection in the next couple of weeks, but the remarkable thing about the MRNA vaccines, Moderna platform is that we can move very fast,” as mentioned in a CNBC article.

The biotechnology company is also developing a 100-microgram booster dose compared to its authorized booster dose of 50-microgram of its COVID-19 vaccine. Moderna has informed that the higher dose of its booster shot has resulted in the highest neutralizing titers against the previous SARS-CoV-2 strains in an ongoing study conducted by the National Institutes of Health in the United States. In the company’s fight against the new COVID-19 variant, Paul Burton has said that “If we have to make a brand new vaccine I think that’s going to be early 2022 before that’s really going to be available in large quantities,” per a CNBC article.

Notably, the FDA has recently broadened the emergency use authorization (EUA) approval of Moderna’s COVID-19 vaccine booster shot at the 50 µg dose level to all adults aged 18 and above. The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has also issued a recommendation suggesting a booster dose. In fact, all the 11 ACIP members unanimously recommended the booster dose.

The authorization has come at a time when travel restrictions are easing and the outbreak is spreading alarmingly in Europe. Thus, the approval can be further helpful in containing the coronavirus outbreak in the United States. Moderna’s sales figures are also expected to get the boost with the latest approval.

It is important to note that the booster shot can be administered to all individuals aged 18 years and above and have completed the primary vaccination with any of the authorized or approved COVID-19 vaccines. At least six months post-completion of the second dose of the primary series, one can opt for the booster shot.

Moderna ETFs to Gain

Considering the important role played by the coronavirus vaccines in Moderna’s recent earnings results, the latest developments can be a positive for the stock. Interestingly, Moderna reported revenues of $4.8 billion in the third quarter.

The company projects product sales between $15 billion and $18 billion for 2021. Moderna had previously stated that it has advance purchase agreements for its COVID-19 vaccine worth $20 billion in place. However, the supply of some doses scheduled for 2021 is being postponed to 2022 on several factors, including longer delivery lead times for international shipments.

The major increase in revenues was driven by sales of its coronavirus vaccine, which is now approved for temporary/emergency use in several countries. Moreover, grants from an agreement with the Biomedical Advanced Research and Development Authority related to the development of the COVID-19 vaccine drove revenues. Therefore, we discuss a few ETFs that provide exposure to Moderna:

ETFMG Treatments Testing and Advancements ETF — up 6.5% since Nov 24

ETFMG Treatments Testing and Advancements ETF is designed to give direct exposure to biotech companies directly engaged in the testing and treatment of infectious diseases.

ETFMG Treatments Testing and Advancements ETF holds 78 stocks in its basket, with Moderna occupying the third spot at 6.39% share. The fund has amassed $52 million in its asset base. ETFMG Treatments Testing and Advancements ETF charges 68 basis points (bps) in annual fees (read: Bet On COVID-Themed ETFs as New Cases Rise Globally).

VanEck Biotech ETF  — up 3.2%

The underlying MVIS US Listed Biotech 25 Index tracks the overall performance of companies involved in the development, production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

VanEck Biotech ETF holds about 25 securities in its basket, with 10.41% exposure to Moderna. Its AUM is $567.4 million and VanEck Biotech ETF has an expense ratio of 0.35% (read: ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus).

iShares Biotechnology ETF  — up 1.7%

iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.

iShares Biotechnology ETF holds about 265 securities in its basket, with 7.88% exposure to Moderna. IBB has an AUM of $9.85 billion, with an expense ratio of 0.45%.

iShares Genomics Immunology and Healthcare ETF  — up 1.9%

iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

iShares Genomics Immunology and Healthcare ETF holds about 49 securities in its basket, with 6.36% exposure to Moderna. IDNA has an AUM of $341.6 million. iShares Genomics Immunology and Healthcare ETF has an expense ratio of 0.47%.


Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.

Get it free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

Moderna, Inc. (MRNA): Free Stock Analysis Report

 

iShares Biotechnology ETF (IBB): ETF Research Reports

 

VanEck Biotech ETF (BBH): ETF Research Reports

 

iShares Genomics Immunology and Healthcare ETF (IDNA): ETF Research Reports

 

ETFMG Treatments, Testing and Advancements ETF (GERM): ETF Research Reports

 

To read this article on Zacks.com click here.

 

Zacks Investment Research

News Related

OTHER NEWS

10 Dividend ETFs Up At Least 4% This Year & Yielding At Least 3%

Dividend is among the investing themes that should be under radar amid the ongoing uncertainty in the markets caused by rising inflation and rising rate worries. Wall Street has been ... Read more »

Signet (SIG) Posts Stellar Holiday Results & Raises View

Signet Jewelers Limited SIG delivered a stellar performance this holiday season. Solid gains from growth initiatives like unique banner value propositions and advanced connected-commerce capabilities drove the holiday performance. SIG’s ... Read more »

Done Is Better Than Perfect and Other Lessons for the Hesitating Entrepreneur

I am so grateful to this week’s guest of SUCCESS Line for sharing their inspiring story. Tara is a mother, wife, real-estate agent, owner of a vegan restaurant and recent ... Read more »

CEO of Major Bank Receives $3 Million Salary Bump

It’s not a radical concept for CEOs to have exorbitant salaries. Alex Wroblewski | Getty Images In the wake of the pandemic and job losses, many CEOs and founders took ... Read more »

Be Smart About Taxes and Keep More of Your Hard-Earned Cash

Taxes can be costly. These costs cut into your income and can have devastating effects on your quality of life, especially in times of transition. Although marketing is my main business, ... Read more »

The Stock Market is Down Today: Here's Why & 3 Penny Stocks To Watch

The stock market is down today. This can be attributed to various reasons, including global economic conditions, interest rates, and company performance. However, there are also opportunities in times like ... Read more »

Is Boot Barn (BOOT) a Solid Growth Stock? 3 Reasons to Think " Yes "

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market’s attention and produce exceptional returns. However, it isn’t easy to find a ... Read more »

Zealand (ZEAL) Ends Enrollment in Short Bowel Syndrome Study

Denmark-based Zealand Pharma A/S ZEAL announced that it has completed enrollment of patients in the pivotal phase III EASE-SBS 1 study that is evaluating its long-acting GLP-2 analog, glepaglutide, for ... Read more »

Top Analyst Reports for Walmart, Micron & Enbridge

Friday, January 21, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Walmart ... Read more »

Charles River (CRAI) Stock Up 44% in a Year: Here's Why

Shares of Charles River AssociatesCRAI have returned 44% over the past year, outperforming 34.7% growth of the industry it belongs to in the said time frame. – Zacks Image Source: ... Read more »

Key Factors to Impact Boston Properties (BXP) in Q4 Earnings

Boston Properties, Inc. BXP is slated to report fourth-quarter and full-year 2021 results on Jan 25, 2022, after market close. BXP’s quarterly results are likely to reflect year over year ... Read more »

Tesla vs. Fisker: Which Electric Vehicle Stock is a Better Buy?

Today I’ll analyze and compare Tesla (TSLA) and Fisker (FSR) to determine which electric vehicle (EV) stock is currently the better investment. shutterstock.com – StockNews The electric vehicle (EV) industry ... Read more »

Is Deutsche Telekom AG (DTEGY) a Solid Growth Stock? 3 Reasons to Think " Yes "

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market’s attention and produce exceptional returns. However, it isn’t easy to find a ... Read more »

Why Bar Harbor Bankshares (BHB) is a Great Dividend Stock Right Now

Whether it’s through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you’re an income investor, your primary focus is ... Read more »

BankUnited (BKU) Q4 Earnings & Revenues Beat, Stock Down 6.48%

BankUnited, Inc.’s BKU fourth-quarter 2021 earnings per share of $1.41 surpassed the Zacks Consensus Estimate of $1.14. The bottom line also jumped 58.4% from the prior-year quarter.Results primarily benefited from ... Read more »

3 Reasons Why JB Hunt (JBHT) Is a Great Growth Stock

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market’s attention and produce exceptional returns. But finding a growth stock that can ... Read more »

What Net Worth Do You Need to Retire?

At some point, you will have to ask an important question, “I much do I need to retire?” Due – Due There are actually several rules of thumb when it ... Read more »

Is EastGroup Properties (EGP) a Solid Growth Stock? 3 Reasons to Think " Yes "

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market’s attention and deliver solid returns. But finding a growth stock ... Read more »

Getting Ready For The Next Leg Up

With the market pulling back from their recent highs, now’s the time to start getting ready for the next leg up.After heady gains last year, the market was ripe for ... Read more »

Surfshark One Gives You a Single Cybersecurity Solution

With cyberattacks against small businesses on the rise in 2021, you need to make sure your business is protected from threats in 2022. That means investing in digital solutions to ... Read more »

A lasting stock market downturn can be a big problem early in your retirement. How to combat that risk

Anchiy | E+ | Getty Images For investors whose retirement is decades away, the stock market's pullback should be of little concern — there's plenty of time for your portfolio ... Read more »

‘No SALT, no deal.' Some House Democrats say deduction must be in Build Back Better

Rep. Tom Suozzi, D-N.Y., speaks during a news conference announcing the State and Local Taxes (SALT) Caucus outside the U.S. Capitol on April 15, 2021.Sarah Silbiger | Bloomberg | Getty ... Read more »

Revisiting the Perks and Perils of Entrepreneurship Amid the Pandemic

In June 2019, I made the bold decision of opening up and running my small marketing and communications consultancy, The Sophia Consulting Firm. I had no idea that the world ... Read more »

How To Sell Your Screenplay To Netflix

The days of cable TV are limited. Streaming services, with Netflix leading the charge, have become the preferred method for people to watch their favorite shows and movies. With no ... Read more »

This Is What Separates a Thriving Company From a Dying One

The noise of bureaucracy. Some old traditions die hard. The pandemic has presented a rapid change in our environment, forcing companies that want to survive to optimize and adapt. Necessity ... Read more »

How Customer Discovery Can Significantly Enhance Your Product-Market Fit

For entrepreneurs and startups, coming up with an idea for a new product or service can be exciting. It may be tempting to charge into the marketplace with an unreasonable ... Read more »

Mark Cuban Launches Online Pharmacy, Promises Lowest Prices on Lifesaving Prescriptions

Billionaire investor and Dallas Mavericks owner Mark Cuban has launched an online pharmacy that offers more than 100 lifesaving medications at what it claims are “affordable” prices.  As a registered ... Read more »

Biden's $15 minimum wage hike for federal agencies is now in effect

U.S. President Joe Biden delivers remarks alongside Intel CEO Patrick Gelsinger (L) and Commerce Secretary Gina Raimondo as he speaks about the ongoing supply chain problems in the South Court ... Read more »

AGNC Investment (AGNC) Stock Moves -0.73%: What You Should Know

In the latest trading session, AGNC Investment (AGNC) closed at $14.95, marking a -0.73% move from the previous day. This change was narrower than the S&P 500’s daily loss of ... Read more »

4 Marketing Strategies That Will Turn Your Customers Into Billboards for Your Business

People love to talk about great experiences. After all, when you really enjoy something, it’s human nature to want to tell others all about it! As a business owner, your ... Read more »

PTC India board to meet Jan 22 after allegations of irregularities in financial lending units

PTC India will hold its first board meeting on Saturday following recent allegations of lapses in governance and operations at its financial lending units. Rajib Mishra, the company’s chairman, did ... Read more »

Peloton Shares Rise After CEO Writes the Company is Considering Layoffs: 'We Now Need to Evaluate Our Organization Structure and Size of our Team'

On Thursday, Peloton CEO John Foley sent a memo to the Peloton team in the form of an open letter on its website, firing back at a report by CNBC alleging to have ... Read more »

In the Big Tech Metaverse, is privacy an option?

The world’s largest companies go all-in on Metaverse, an alternative virtual reality world combining work, leisure, services and more. While they look for the best way to make everyone join ... Read more »

Why Is The Airline Industry So Concerned With The 5G Network?

While AT&T Inc (NYSE:T) and Verizon Communications Inc (NYSE:VZ) announced ambitious plans to deploy 5G services in the U.S., the airline industry has raised concerns about how this technology could ... Read more »

Y Combinator-backed Invoid joins Credenc, a Capital India company to build Neobank for students

Invoid, a Y Combinator-backed firm, has joined Credenc, an online platform for education loans, to build a student focused Neobank, a first in India for college students. The company said ... Read more »

How to Be More Courageous in Life

Do you have a lot of fears in life? Are you struggling with the fear of failure, the fear of uncertainty and the fear of success? You don’t have to ... Read more »

An Inspiring Interview with Steve White, President, Special Counsel to the CEO of Comcast

Do you let circumstances define who you are, or do you take charge of your life no matter how challenging it is? I have the pleasure to interview Steve White, ... Read more »

Silver Jewellery Startup GIVA Raises $10 Million In Series A

Bengaluru-based silver jewellery startup GIVA, has raised  $10 million in its Series A funding led by Sixth Sense Ventures, A91 Partners and other marquee investors like India Quotient, Grand Anicut ... Read more »

Cloud Tailor Raises $1 Million In Pre-Series A

Cloud Tailor, a D2C platform that enables personalized women’s fashion, has raised $1.0 million in its pre-Series A round led by 35North Ventures and Mergerdomo. Pexels Two of Cloud Tailor’s ... Read more »

Big Tech Uses Data to the Detriment of Consumer Health, But We're Addicted. So What's the Solution?

As was brilliantly chronicled in the 2020 Netflix documentary The Social Dilemma, much of tech today uses data to tap into the human brain in a way that is detrimental to ... Read more »
On free-english-test.com you will find lots of free English exam practice materials to help you improve your English skills: grammar, listening, reading, writing, ielts, toeic